Delivery Order SPE2DR25D3301-SPE2DR26F21ND
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Acyclovir 1,000 mg/20 mL vials with a ceiling value of $10,567.63. This firm fixed-price delivery order, which must be completed by January 30, 2026, represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was awarded through full and open...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 29, 2026, for the supply of Acyclovir 1,000 mg/20 ml vials with a contract value of $2,016.00 and a completion date of January 30, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded through open and full competition. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Acyclovir 500 mg/10 mL vials with a ceiling value of $1,228.00. This is a firm fixed price delivery order, awarded on January 2, 2026, with an ultimate completion date of January 5, 2026. The contract represents a non-competitive set-aside award and will be performed at the company's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.36 to AmerisourceBergen Drug Corp for the supply of Acyclovir 1,000 mg/20 mL vials. This firm fixed-price, non-set-aside contract was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction supporting federal medical supply requirements for antiviral...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corporation, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, a Delivery Order contract worth $1,641.12 for 4,565,410,300 units of Acyclovir 1,000 mg/20 ml vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the DLA to efficiently procure...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,037.41 delivery order is for the supply of 4,557,986,323 units of Acyclovir 1,000 mg/20 ml vials. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract provides for the delivery of 4,564,205,739 units of the pharmaceutical product Acyclovir 200 mg/5 ml suspension in 473 ml bottles. The delivery order has a ceiling value of $3,850.88 and a completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a $1,787.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664392 - Acyclovir 200 mg/5 ml suspension in 473 ml bottles. The contract has a completion date of September 4, 2024 and was awarded on September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency awarded a $1,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 mg/10 ml vials of acyclovir. As the prime contractor, Amerisourcebergen will deliver the antiviral medication to a location in Conshohocken, Pennsylvania by September 20, 2023 under the terms of this order. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp provides for the delivery of Acyclovir 200 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order is valued at $3,098.92 and has a period of performance through July 10, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21NDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,080.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Acyclovir 500 mg/10 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not set aside for any specific business classification and was competitively awarded. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order was issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and effective through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The delivery order reflects routine pharmaceutical procurement to support Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/28/26 |